Stocksigma LogoStocksigma Logo

Rossari Biotech Posts Record Q2 FY27 Financial Results with Strategic Global Expansion

Rossari Biotech reported record quarterly consolidated revenue of Rs. 697.6 crores, up 19.0% YoY, and highest-ever EBITDA of Rs

Rossari Biotech Posts Record Q2 FY27 Financial Results with Strategic Global Expansion

Rossari Biotech Ltd 路 Press Release 路 19 Oct 2026, 6:18 am

Rossari Biotech Posts Record Q2 FY27 Financial Results with Strategic Global Expansion Rossari Biotech reported record quarterly consolidated revenue of Rs. 697.6 crores, up 19.0% YoY, and highest-ever EBITDA of Rs. 87.0 crores, up 20.9% YoY with margins at 12.5% (+20 bps). Q2 PAT stood at Rs. 38.9 crores, subdued by higher depreciation. Export sales rose 33.8% YoY to Rs. 216.4 crores. As of Sep'26, net debt fell to Rs. 221 crores from Rs. 281 crores in Mar'26. Additionally, the board approved land leasing for a greenfield manufacturing plant in Saudi Arabia.

Original exchange filing (PDF)

More announcements from Rossari Biotech Ltd

All Rossari Biotech Ltd announcements